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Abstract
Bacterial conjugation is the main mechanism for the dissemination of multiple antibiotic
resistance in human pathogens. This dissemination could be controlled by molecules that
interfere with the conjugation process. A search for conjugation inhibitors among a collec-
tion of 1,632 natural compounds, identified tanzawaic acids A and B as best hits. They spe-
cially inhibited IncW and IncFII conjugative systems, including plasmids mobilized by them.
Plasmids belonging to IncFI, IncI, IncL/M, IncX and IncH incompatibility groups were tar-
geted to a lesser extent, whereas IncN and IncP plasmids were unaffected. Tanzawaic
acids showed reduced toxicity in bacterial, fungal or human cells, when compared to syn-
thetic conjugation inhibitors, opening the possibility of their deployment in complex environ-
ments, including natural settings relevant for antibiotic resistance dissemination.
Introduction
Infections due to antibiotic-resistant (AbR) enterobacteria are a worldwide cause of morbidity
and mortality [1]. Moreover, the interest in developing new antibiotics by the pharmaceutical
industry is declining due to high development costs and the ability of bacteria to evolve quickly
and thus overcome antibiotic action [2]. As AbR genes disseminate mostly by conjugation [3,
4], we proposed a new strategy to control AbR dissemination before infection, targeting AbR
plasmid conjugation [5, 6]. Efforts to control conjugation include either targeting specific com-
ponents [7–9] or the overall conjugation process [6, 10]. However, only unsaturated fatty acids
(uFAs) were considered effective compounds in practice to inhibit plasmid conjugation in
enterobacteria [6, 10]. Bisphosphonates, on the other hand, were recently revealed as nonspe-
cific chelating agents [11] instead of specific inhibitors of plasmid F relaxase [7].
Among previously discovered conjugation inhibitors (COINs), the most potent to date,
dehydrocrepenynic acid [6], is extracted from tropical plant seeds [12]. uFAs, such as oleic and
linoleic acids, have double bonds susceptible to oxidation [13]. Although triple-bonded fatty
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acids 2-hexadecynoic acid (2-HDA) and 2-octadecynoic acid (2-ODA) are promising COINs,
easily synthesized [14–16] and capable of preventing plasmid invasiveness in a bacterial popu-
lation [10], they have toxicity issues that must be overcome. Although 2-HDA showed no tox-
icity in Escherichia coli, it was found to be toxic for fungi [17, 18], protozoa [14, 15], gram
positive bacteria, some gram-negative bacteria and eukaryotic cells [16, 19, 20]. Because
COINs act as prophylactic molecules, but do not elicit a direct therapeutically action, their
practical application requires administration in environmental settings where plasmid conju-
gation occurs. Thus, COIN toxicity must be reduced, ideally completely eliminated, while
chemical stability has to be maintained.
We decided to screen AQUAc, a collection of bioactive compounds isolated from aquatic
microorganisms, in a search for better COINs. We expected to find compounds with different
target specificity, better potency and stability, or less toxic to different cell types. The com-
pound collection was tested by using a whole-cell automated assay. As a result, tanzawaic acids
(TZAs) A and B were discovered as natural COINs with reduced toxicity compared to synthetic
ones, able to inhibit bacterial conjugation of an important fraction of relevant plasmid groups.
Results
High-throughput conjugation (HTC) screening of AQUAc collection
A total of 1,632 partially purified natural compounds extracted from a diversity of marine
microorganisms (mainly actinomycetes, fungi and micro-algae) constitute the AQUAc collec-
tion from Biomar Microbial Technologies. It contains a high percentage of novel chemical
structures (http://www.biomarmicrobialtechnologies.com). The AQUAc collection was ana-
lyzed using a luminescence-based HTC screening assay [6]. The IncW plasmid R388 was
selected as the test plasmid due to its simple genetic organization [21] and its widespread mat-
ing pair formation (MPF) system, similar to that of the well-known Agrobacterium tumefaciens
Ti plasmid [22]. A total of 9 compounds showed luminescence values under the selected
threshold at tested concentrations and were chosen as best hits (S1 Fig). Control assays were
carried out to discard hits affecting bacterial growth, plasmid stability, lux expression or light
production. None of the selected compounds (except perhaps P515) reduced luminescence of
control cells containing plasmid pSU2007::Tnlux, which emits light constitutively (S2 Fig).
Potency assays were subsequently carried out to select the most effective COINs (S1 Table).
Two promising hits, P515 and P605, were selected for further analysis. Confirmation of COIN
activity by plate-conjugation assays carried out in triplicate (at 50 μg/ml COIN concentration)
resulted in relative frequency values of 1% for compound P515 and 20% for compound P605,
respectively. Scale-up fermentations of the appropriate organisms were performed, bulk har-
vested biomass was extracted and serial HTC-guided fractionation was carried out to purify
the active compounds present in P515 and P605 producer strains.
TZAs A and B inhibit R388 conjugation
Fractionation of extracts obtained from P515 and P605 producer strains was guided by a HTC
assay based on fluorescence emission by transconjugant cells [10]. Re-fermentation of the
P515-producing strain did not allow the purification of any active compound. Guided fraction-
ation of P605 allowed the purification of one active compound, whose structure was elucidated
by nuclear magnetic resonance (Fig 1). The new COIN was identified as TZA-B, a polyketide
previously described as inhibitor of superoxide anion production from Penicillium citrinum
[23, 24]. Dose/response analysis of TZA-B was also performed by fluorescence-based HTC
assay. As a result, 0.4 mM TZA-B was found to inhibit R388 conjugation to 2% (Fig 2), as con-
firmed by plate-conjugation assay (2 ± 2%).
Natural Conjugation Inhibitors
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In the same way as TZA-B, two of its structural analogs, namely TZAs A and E (Fig 3A), are
also inhibitors of superoxide anion production [23, 24]. They were also checked as possible
COINs. While TZA-A inhibited R388 conjugation to levels similar to TZA-B, TZA-E, carrying
an additional hydroxyl group in its chemical structure, did not show significant COIN activity
(Fig 3B). Interestingly, TZA-A was present in one of the 9 hits selected in the primary HTC
assay (S1 Fig), specifically AD0103 (S2 Fig), which contained 60% pure TZA-A.
Fig 1. Structural elucidation of TZA-B. (A) Chemical structure of TZA-B, indicating carbon positions. (B) 1H
and 13C NMR spectral data of TZA-B [δ (ppm), JHH (Hz); CDCl3].
doi:10.1371/journal.pone.0148098.g001
Natural Conjugation Inhibitors
PLOS ONE | DOI:10.1371/journal.pone.0148098 January 26, 2016 3 / 13
IncW and IncF conjugative plasmids, main targets
A collection of clinically representative conjugative plasmids found in Enterobacteriaceae was
tested to investigate the range of TZA-B susceptible plasmids. Results are shown in Fig 4. Con-
jugation of the IncW plasmid R388 and the IncFII plasmid R100-1 was specially inhibited in
the presence of TZA-B, almost 100-fold at 0.4 mM concentration. Besides, IncFI (pOX38),
IncFII (R1drd19), IncI (R64drd11), IncL/M (pCTX-M3), IncX (R6K) and IncH (drR27) plas-
mids were also inhibited, although to a lesser extent (CF from 10 to 50%). Other plasmid
groups, such as IncN and IncP, were not affected.
TZA-B inhibits mobilization helped by IncW and IncF plasmids
In addition to conjugative plasmids, mobilizable plasmids are also important carriers of AbR
genes. For mobilization, they need the MPF system of a conjugative plasmid present in the
donor cell, and even its coupling protein in some cases (ColE1 and RSF1010). To find out
which mobilizable plasmids were affected by TZA-B, mobilization of ColE1, RSF1010 and
CloDF13 was analyzed in the presence of different helper plasmids. As shown in Fig 5, mobili-
zation of plasmids CloDF13 (which encodes its own coupling protein) or ColE1 was affected
when the helper plasmid used was itself susceptible to TZA-B (R388, pOX38 or R100-1). On
the other hand, mobilization of ColE1 and RSF1010 plasmids helped by the COIN-resistant
plasmid pRL443, was unaffected.
Toxicity of natural and chemically synthesized COINs
Toxicity of COINs must be analyzed to select compounds that affect minimally the biodiversity
of the targeted ecosystem. It was previously shown that concentrations around the COIN-IC50
dose are enough for a compound to prevent the spread of a conjugative plasmid in a bacterial
population [10]. Thus, in order to assess the toxicity levels of different COINs, we must
Fig 2. Conjugation frequency (CF) in the presence of increasing concentrations of TZA-B. Values
represent the mean CF ± SD of at least four independent experiments, measured by fluorescence-based
HTC assay and relative to positive control in the absence of COINs (100%).
doi:10.1371/journal.pone.0148098.g002
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determine whether levels below the COIN-IC50 exert toxic effects in higher organisms or
microbial species. For this purpose, we compared cytotoxic, antibacterial and antifungal activi-
ties of the various types of COINs discovered to date, using a variety of human cell lines, bacte-
rial and fungal strains. As shown in Table 1, toxicity values (toxic-IC50) of all COINs on
human cell lines was around 100 μM. Antibacterial and antifungal activities were more vari-
able. Synthetic 2-ODA was bactericidal (toxic-IC90) over 7 μM versusMycobacterium smegma-
tis. 2-HDA was bactericidal versusM. smegmatis and fungicidal versus Aspergillus nidulans
and Candida albicans at similar levels. On the contrary, TZA-A, TZA-B, oleic and linoleic
acids showed significantly lower antibacterial and antifungal activities, their toxic-IC90 values
ranging over 100 μM.
Discussion
COIN application in clinical and environmental settings demands non-toxic, easy to obtain,
chemically and biologically stable molecules. COINs discovered to date have limitations that
Fig 3. TZAs A, B and E structure and activity. (A) Chemical structure of TZAs A, B, and E. (B) CF of
plasmid R388, measured by plate-conjugation assay and represented in logarithmic scale in the presence of
1 mM TZAs A, B, or E. C+, control in the absence of added compound. Bars represent the mean CF + SD of
at least three independent experiments (*** p < 0.001).
doi:10.1371/journal.pone.0148098.g003
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deviate from ideality, such as obtainability, stability or toxicity [6, 10]. For that reason, a collec-
tion of natural compounds extracted from marine microorganisms was screened to find com-
pounds suitable for environmental use. Using AQUAc, a collection of partially purified natural
Fig 4. CF of prototype plasmids in the presence of TZA-B.CF in the presence of 0.4 mM TZA-B (TZA-B,
blue squares) or in its absence (C+, orange circles) using a representative set of conjugative plasmids. Each
point represents the result of one independent experiment in logarithmic scale measured by plate-
conjugation assay. Horizontal and vertical bars represent the mean ± SD of each group of data (* p < 0.05,
** p < 0.01, *** p < 0.001). Inc, incompatibility group [25].
doi:10.1371/journal.pone.0148098.g004
Fig 5. Mobilization frequency (MF) in the presence of TZA-B.MF of three mobilizable plasmids in the
presence of 0.4 mM TZA-B (TZA-B, blue squares) or in its absence (C+, orange circles), using four different
helper plasmids. Each point represents the result of one independent experiment in logarithmic scale
measured by plate-conjugation assay. Horizontal and vertical bars represent the mean ± SD of each group of
data (** p < 0.01, *** p < 0.001). a CFs of helper plasmids in the presence of mobilizable plasmids were
similar to that obtained alone (Fig 4).
doi:10.1371/journal.pone.0148098.g005
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compounds, two new COINs, TZA-A and TZA-B, were discovered (Fig 3). Their potency (Fig
2) was similar to that of previously identified uFAs (oleic and linoleic acids) [6] and of the
chemically synthesized 2-HDA [10].
TZAs are fungal polyketides with chemical structures more complex than previously
described COINs [6, 10]. They are carboxylic acids containing two aromatic rings at the end of
an unsaturated aliphatic chain. As a consequence, they belong to the same group as previously
reported inhibitors. The independent isolation of these compounds confirms the essentiality of
these two chemical characteristics (a carboxylic group and a long, unsaturated aliphatic chain)
for COIN activity. Interestingly, the TZA variant TZA-E, which contains an additional
hydroxyl group distal to the carboxylic acid in its chemical structure (Fig 3A), was inactive (Fig
3B). It thus seems that a substantial hydrophobic moiety is important for COIN function, a
characteristic that is functionally broken by a distant single hydroxyl group in the bulky
TZA-E.
In addition to potency and structural similarities, the shared spectra of plasmids affected by
the action of TZAs and previously analyzed COINS points to a common mechanism of inhibi-
tion. IncW and IncF conjugative plasmids, as well as their mobilizable plasmids, represent the
main targets of the COINs described here (Figs 4 and 5) as well as in previous publications [6,
10]. These results suggest a shared target in conjugation and mobilization, probably being part
of the MPF system of affected conjugative plasmids, also used for transfer of mobilizable
plasmids.
TZAs were previously reported to inhibit superoxide anion production [23, 24], nitric oxide
production and protein tyrosine phosphatase 1B activity in inflammatory cells [26]. In addi-
tion, two recent studies analyzed antimicrobial and cytotoxic effects of these fungal polyketides.
TZA-A was found to inhibit conidial germination of the rice blast fungusMagnaporthe oryzae
(toxic-IC50 = 37 μM), and showed weak activity against the Gram-positive bacteria Brevibacil-
lus brevis, the fungiMucor miehei and Paecilomyces variotii, and HeLaS3 cells at a concentra-
tion of 185 μM. Germination of the grey mold Botrytis cinerea and the potato blight caused by
the oomycete Phytophthora infestans were not affected at comparable concentrations [27]. In
an independent work [28], the antimicrobial activity of TZA-B against S. aureus, Salmonella
sp., Klebsiella pneumoniae, E. coli, Bacillus cereus, Proteus mirabilis, Enterococcus faecalis, and
C. albicans showed no effect below 364 μMCOIN concentration. Moreover, leukemic and lym-
phoblastic cell lines (K562, U937, Jurkat and Raji) showed no response at 100 μM. These data,
together with our results (Table 1), situate the TZAs, along with the previously identified oleic
Table 1. Comparative analysis of COIN toxicity properties.
COIN Toxic-IC50 (μM) Toxic-IC90 (μM)
A549 HCT-116 PSN1 T98G Fibroblasts Saur Msme Anid Calb
TZA-A 60 70 90 90 190 230 230 > 230 > 230
TZA-B 90 90 180 180 180 120 120 > 230 > 230
2-HDA 40 40 80 100 100 30 8 8 < 4
2-ODA 90 70 180 150 90 350 7 220 220
Oleic acid 40 180 80 180 350 > 420 > 420 > 220 > 220
Linoleic acid 90 180 90 180 300 > 360 360 > 360 > 360
Toxicity properties of TZA-A and TZA-B compared to previously described COINs [6, 10]. Inhibitory concentrations for cytotoxic (toxic-IC50), antibacterial
and antifungal activities (toxic-IC90) using different human cell lines, bacteria and fungus species (mean value of three independent experiments). Saur,
Staphylococcus aureus; Msme, M. smegmatis; Anid, A. nidulans; Calb, C. albicans.
doi:10.1371/journal.pone.0148098.t001
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and linolenic acids [6], as the least toxic COINS identified so far. A comparison of toxicity val-
ues with the COIN potency of the different molecules tested, revealed that TZA-A, TZA-B,
oleic and linoleic acid presented toxic-IC50 levels that were above their COIN threshold
(COIN-IC50 50 μM) (Fig 2) [6]. 2-HDA and 2-ODA were non-toxic at COIN concentrations
in almost all human cell lines tested (COIN-IC50 50 μM) [10], but exerted strong toxic effects
in mycobacterial and/or fungal species (Table 1). Although TZA-B showed COIN activity at
non-toxic concentrations, cytotoxic and COIN thresholds were too close. A key finding from
this work is that toxicity and COIN activity do not necessarily correlate with each other, since
TZA-B and 2-HDA presented similar COIN-IC50 concentrations, yet the later was more toxic
to bacterial and fungal strains. This opens the possibility of further screening natural and syn-
thetic derivatives with lower toxicity and enhanced COIN activity.
In summary, the COINs reported here and in previous work provide important ammunition
in the search for optimal COINs. Their different characteristics make them applicable to different
purposes. On the one hand, 2-HDA and 2-ODA are easily obtainable by chemical synthesis [14–
16] and have provided important structural information [10]. Nevertheless, their antifungal [17,
18], antiprotozoal [14, 15], antimicrobial and cytotoxic activities [16, 19, 20], exclude their use in
natural environments, where biodiversity must be maintained, and confine their use to academic
setups. On the other hand, TZAs A and B (this work), as well as oleic and linoleic acids [6], are
potentially more unstable, but they are natural compounds with reduced toxicity (Table 1), some
of them being normal constituents of the human diet [29]. This makes them potential COINs for
their use in natural environments, either in combination with effective antioxidants or through
delivery vehicles with a protective atmosphere. In general, COINs show a shared and relatively
broad range of affected plasmids, among them IncF plasmids, the most common AbR carriers in
pathogenic Enterobacteriaceae [30]. Furthermore, non-toxic COINs could be used in ecological
reservoirs of AbR genes, or as a combination treatment with antibiotics to prolong their useful
lifetime, or even as virulence inhibitors for pathogens such as Legionella,Helicobacter, Neisseria,
Brucella or Bartonella, which use secretion systems similar to conjugative systems.
Materials and Methods
Bacterial strains and plasmids
Derivatives of E. coli strain DH5α [31] containing either the conjugative plasmid pJC01 [10] or
plasmids pSU2007::Tnlux and pUC18::lacIq [6] were used as donor strains in fluorescence-
based or luminescence-based HTC experiments, respectively. Rifampicin-resistant derivative
E. coli CSH53 [32] was used as recipient strain in luminescence-based HTC assay and as
pSU2007::Tnlux containing strain in control assays [6]. Streptomycin-resistant derivative E.
coli BL21 (DE3) [33] was used as recipient strain expressing T7 RNA polymerase in fluores-
cence-based HTC assay [10]. E. coli DH5α [31] containing different conjugative and mobiliz-
able plasmids (S2 Table) and a rifampicin-resistant derivative of E. coliMDS52 [34] were used
as donor and recipient strains respectively in plate-conjugation assays.
Reagents
When appropriate, antibiotics (Apollo) were added at the following concentrations: ampicillin
sodium salt (Ap; 100 μg/ml), chloramphenicol (Cm; 25 μg/ml), nalidixic acid (Nx; 20 μg/ml),
rifampicin (Rif; 50 μg/ml), streptomycin (Sm; 300 μg/ml), tetracycline (Tc; 10 μg/ml) and tri-
methoprim (Tp; 10 μg/ml). Oleic and linoleic acids (Sigma-Aldrich) were used as control
COINs, DMSO (Sigma-Aldrich) was used as solvent and IPTG (Sigma-Aldrich) as T7 RNA poly-
merase inductor. Bacterial cultures were set up in LB-broth and LB-agar (Pronadisa). M9 broth
(Sigma-Aldrich) were used to resuspend bacteria after mating and perform serial dilutions.
Natural Conjugation Inhibitors
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Isolation of TZA-B
TZA-B producer Penicillium sp. strain CECT 20935, isolated from a Porifera sp. collected in
Guatemala and grown in potato dextrose agar plates (Pronadisa), was used to inoculate 40 ml
of potato dextrose broth (Pronadisa). This first inoculum was grown for 3 days at 24°C and 200
rpm. Then, 15 ml were added to 250 ml of the same media and cultured for 7 days at 24°C and
200 rpm. Fermentation broth (4 l) was filtered off with dicalite1 (Dicalite Europe) and the
mycelial cake was extracted twice by adding 1.5 l of a mixture of EtOAc/MeOH 3:1 and soaking
for 1 h. The organic solvent was filtered off and the pellet dried under reduced pressure. Dried
extracts (2.8 g) were fractionated by vacuum flash chromatography using a stepwise gradient of
Hexane/EtOAc/MeOH. Fractions containing TZA-B (eluted with Hexane/EtOAc 2:8) were
applied to a silica gel column and flash-chromatographed by elution with a Hexane/EtOAc gra-
dient. Fractions eluted with Hexane/EtOAc 75:25, afforded 105 mg of 93% pure TZA-B.
Structural elucidation of TZA-B
TZA-B has a maximum UV absorption at 300 nm. The molecular formula was determined to
be C18H26O2 based on the MS (m/z 274.3) and NMR spectral data. Extensive NMR experi-
ments (1H NMR, 13CNMR, 1H-1H COSY, gHSQC, gHMBC and NOESY) indicate that TZA-B
has three methyl groups, two methylenes, twelve methines (six of them olefinic), one quater-
nary carbon and one exchangeable proton. These data were identical with those for TZA-B,
previously reported in the literature [23]. 1H-NMR and 13C-NMR data (Fig 1) were recorded
on a Varian “Mercury 400” spectrometer (Agilent Technologies) at 400 and 100 MHz, respec-
tively. gHMQC and gHMBC experiments were carried out using an inverse resonance probe.
Chemical shifts are reported in ppm relative to solvent (CDCl3 δH 7.24, δC 77.0). MS data were
recorded on an Agilent/HP 1100 Series Simple Quad Mass Spectrometer (Agilent Technolo-
gies), using both, ESI (+) y (-) and APCI (+) y (-) ionization sources.
HTC screening
A luminescence-based HTC assay was performed as previously described [6]. Briefly, a lux
operon under the control of a lac promoter encoded in the R388 derivative pSU2007::Tnlux is
repressed in donor cells by the LacIq repressor carried in the co-resident non-mobilizable
multi-copy plasmid pUC18::lacIq. Upon conjugation, pSU2007::Tnlux but not pUC18::lacIq is
transferred to recipient cells, where light is produced. Absolute luminescence emitted by trans-
conjugant cells was then measured and normalized to the mean value of the corresponding
plate. Control assays to discard non-specific compounds were carried out by growing a
pSU2007::Tnlux containing strain without plasmid pUC18::lacIq and measuring light produc-
tion. Similarly, HTC assay based on the emission of fluorescence employed plasmid pJC01 as
test plasmid [10]. In donor cells, the gfp gene present in this R388 derivative is not expressed,
due to the inactivity of its T7 promoter. When pJC01 plasmid is transferred to the recipient
strain, which carries T7 RNA polymerase, GFP is produced. CF was estimated as the ratio of
absolute fluorescence emitted by transconjugant cells and OD600 as a measurement of the total
number of cells. Relative CF in the presence of a compound was thus determined as a fraction
of the CF in the absence of it (adding the same volume of solvent).
Plate-conjugation assay
For the plate-mating procedure, a 200 μl mixture of equal volumes of donor and recipient cul-
tures previously washed, both in stationary phase, was centrifuged and resuspended in 15 μl
LB-broth. 5 μl of this mixture were placed on top of 96-well microtiter plate wells containing
Natural Conjugation Inhibitors
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150 μl LB-agar (± COINs) and conjugation was allowed to proceed, in general, for 1 h at 37°C.
The temperature-sensitive IncH plasmid drR27 was allowed to conjugate for 2 h at 25°C [35].
Bacteria were then resuspended in 150 μl M9 broth and corresponding dilutions were plated
on selective media. CF was calculated as the number of transconjugant cells per donor, whereas
MF was calculated as the number of cells receiving the mobilizable plasmid per donor. Since
this type of frequency data were log-normally distributed, means are calculated using decimal
logarithms of data. Relative CF or MF in the presence of a compound was determined as a frac-
tion of the CF of MF in the absence of it (adding the same volume of solvent).
Toxicity assays
Cell culture cytotoxicity assays were performed as described [36, 37] using human foreskin
fibroblasts ATCC SCRC-1041 [38], lung carcinoma cells A549 [39], colorectal carcinoma cells
HCT-116 [40], pancreatic adenocarcinoma cells PNS1 [41] or glioblastoma multiforme cells
T98G [42]. Antibacterial activity was determined using a conventional microtiter broth-dilu-
tion technique [43] for two reference strains, S. aureus CECT 794 andM. smegmatis DSMZ
43756. Antifungal activity was measured using the reference method antifungal broth dilution
susceptibility test (National Committee for Clinical Laboratory Standars) against two species:
A. nidulans (Microorganisms Collection of Biomar Microbial Technologies) and C. albicans
CECT 1394.
Statistical analysis
Mean comparison between two different conditions was carried out by using t test tool from
GraphPad Prism1 (v 5.0) biostatistics software (San Diego, CA).
Supporting Information
S1 Fig. Point cloud representation obtained from AQUAc HTC screening. Absolute lumi-
nescence emitted by transconjugant cells was measured in arbitrary light units (A. L. U.) and
normalized to the mean value of the corresponding plate (100%). Each point represents the
mean of two independent experiments obtained by luminescence-based HTC assay in the pres-
ence of bactericidal or non-bactericidal compounds (220 ng/ml or 11 μg/ml, respectively). A
relative luminescence cutoff of 10% was arbitrarily established (red) to select the most active
compounds. Oleic and linoleic acids (green) were used at 1 mM concentration as control
COINs.
(TIF)
S2 Fig. Kinetic luminescence assay of selected hits from AQUAc screening. E. coli CSH53
containing pSU2007::Tnlux (but not pUC18::lacIq) was cultured overnight, diluted until OD600
= 0.1 and grown for 2 h in the absence (C+) or the presence of each potential inhibitor (50 μg/
ml). The figure shows the kinetics of light emission, measured every 5 min and represented
over time.
(TIF)
S1 Table. Potency of AQUAc selected hits. CF in the presence of selected hits from AQUAc
screening. Absolute luminescence emitted by transconjugant cells was measured in A.L.U. and
relativized to the control in the absence of added COINs (100%). Each value represents the
mean of two independent experiments obtained by luminescence-based HTC assay in the pres-
ence of the given concentrations of selected hits. The hyphen represents no data for that point.
(DOCX)
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S2 Table. Conjugative and mobilizable plasmids used.
(DOCX)
Author Contributions
Conceived and designed the experiments: AF FdlC. Performed the experiments: MG RFL CPG
JCG JMSL MM. Analyzed the data: MG RFL JCG FdlC. Wrote the paper: MG RFL FdlC.
References
1. Hawkey PM, Jones AM. The changing epidemiology of resistance. The Journal of antimicrobial chemo-
therapy. 2009; 64 Suppl 1:i3–10. PMID: 19675017. doi: 10.1093/jac/dkp256
2. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no
ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48(1):1–
12. PMID: 19035777. doi: 10.1086/595011
3. Halary S, Leigh JW, Cheaib B, Lopez P, Bapteste E. Network analyses structure genetic diversity in
independent genetic worlds. Proceedings of the National Academy of Sciences of the United States of
America. 2010; 107(1):127–32. Epub 2009/12/17. doi: 10.1073/pnas.0908978107 PMID: 20007769;
PubMed Central PMCID: PMC2806761.
4. Norman A, Hansen LH, Sorensen SJ. Conjugative plasmids: vessels of the communal gene pool. Philo-
sophical transactions of the Royal Society of London Series B, Biological sciences. 2009; 364
(1527):2275–89. Epub 2009/07/03. doi: 10.1098/rstb.2009.0037 PMID: 19571247; PubMed Central
PMCID: PMC2873005.
5. Baquero F, Coque TM, de la Cruz F. Ecology and evolution as targets: the need for novel eco-evo
drugs and strategies to fight antibiotic resistance. Antimicrobial agents and chemotherapy. 2011; 55
(8):3649–60. PMID: 21576439. doi: 10.1128/AAC.00013-11
6. Fernandez-Lopez R, Machon C, Longshaw CM, Martin S, Molin S, Zechner EL, et al. Unsaturated fatty
acids are inhibitors of bacterial conjugation. Microbiology (Reading, England). 2005; 151(Pt 11):3517–
26. PMID: 16272375.
7. Lujan SA, Guogas LM, Ragonese H, Matson SW, Redinbo MR. Disrupting antibiotic resistance propa-
gation by inhibiting the conjugative DNA relaxase. Proceedings of the National Academy of Sciences of
the United States of America. 2007; 104(30):12282–7. PMID: 17630285.
8. Garcillan-Barcia MP, Jurado P, Gonzalez-Perez B, Moncalian G, Fernandez LA, de la Cruz F. Conjuga-
tive transfer can be inhibited by blocking relaxase activity within recipient cells with intrabodies. Molecu-
lar microbiology. 2007; 63(2):404–16. PMID: 17163977.
9. Lin A, Jimenez J, Derr J, Vera P, Manapat ML, Esvelt KM, et al. Inhibition of bacterial conjugation by
phage M13 and its protein g3p: quantitative analysis and model. PloS one. 2011; 6(5):e19991. PMID:
21637841. doi: 10.1371/journal.pone.0019991
10. Getino M, Sanabria-Rios DJ, Fernandez-Lopez R, Campos-Gomez J, Sanchez-Lopez JM, Fernandez
A, et al. Synthetic Fatty Acids Prevent Plasmid-Mediated Horizontal Gene Transfer. MBio. 2015; 6(5).
Epub 2015/09/04. doi: 10.1128/mBio.01032-15 PMID: 26330514; PubMed Central PMCID:
PMC4556808.
11. Nash RP, McNamara DE, BallentineWK 3rd, Matson SW, Redinbo MR. Investigating the impact of bis-
phosphonates and structurally related compounds on bacteria containing conjugative plasmids. Bio-
chemical and biophysical research communications. 2012; 424(4):697–703. PMID: 22796221. doi: 10.
1016/j.bbrc.2012.07.012
12. Gussoni M, Greco F, Pegna M, Bianchi G, Zetta L. Solid state and microscopy NMR study of the chemi-
cal constituents of Afzelia cuanzensis seeds. Magn Reson Imaging. 1994; 12(3):477–86. Epub 1994/
01/01. PMID: 8007778.
13. Niki E, Yoshida Y, Saito Y, Noguchi N. Lipid peroxidation: mechanisms, inhibition, and biological
effects. Biochemical and biophysical research communications. 2005; 338(1):668–76. Epub 2005/08/
30. S0006-291X(05)01776-6 [pii] doi: 10.1016/j.bbrc.2005.08.072 PMID: 16126168.
14. Tasdemir D, Sanabria D, Lauinger IL, Tarun A, Herman R, Perozzo R, et al. 2-Hexadecynoic acid inhib-
its plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections. Bioor-
ganic & medicinal chemistry. 2010; 18(21):7475–85. PMID: 20855214.
15. Carballeira NM, CartagenaM, Sanabria D, Tasdemir D, Prada CF, Reguera RM, et al. 2-Alkynoic fatty
acids inhibit topoisomerase IB from Leishmania donovani. Bioorganic & medicinal chemistry letters.
2012; 22(19):6185–9. PMID: 22932312.
Natural Conjugation Inhibitors
PLOS ONE | DOI:10.1371/journal.pone.0148098 January 26, 2016 11 / 13
16. Sanabria-Rios DJ, Rivera-Torres Y, Maldonado-Dominguez G, Dominguez I, Rios C, Diaz D, et al. Anti-
bacterial activity of 2-alkynoic fatty acids against multidrug-resistant bacteria. Chemistry and physics of
lipids. 2014; 178:84–91. PMID: 24365283. doi: 10.1016/j.chemphyslip.2013.12.006
17. Gershon H, Shanks L. Antifungal properties of 2-alkynoic acids and their methyl esters. Canadian jour-
nal of microbiology. 1978; 24(5):593–7. PMID: 26458.
18. Carballeira NM, Sanabria D, Cruz C, Parang K, Wan B, Franzblau S. 2,6-Hexadecadiynoic acid and
2,6-nonadecadiynoic acid: novel synthesized acetylenic fatty acids as potent antifungal agents. Lipids.
2006; 41(5):507–11. PMID: 16933795.
19. KonthikameeW, Gilbertson JR, Langkamp H, Gershon H. Effect of 2-alkynoic acids on in vitro growth
of bacterial and mammalian cells. Antimicrobial agents and chemotherapy. 1982; 22(5):805–9. PMID:
7181490.
20. Morbidoni HR, Vilcheze C, Kremer L, Bittman R, Sacchettini JC, JacobsWR Jr. Dual inhibition of myco-
bacterial fatty acid biosynthesis and degradation by 2-alkynoic acids. Chemistry & biology. 2006; 13
(3):297–307. PMID: 16638535.
21. Fernandez-Lopez R, Del Campo I, Revilla C, Cuevas A, de la Cruz F. Negative feedback and transcrip-
tional overshooting in a regulatory network for horizontal gene transfer. PLoS genetics. 2014; 10(2):
e1004171. Epub 2014/03/04. doi: 10.1371/journal.pgen.1004171 PMID: 24586200; PubMed Central
PMCID: PMC3937220.
22. Christie PJ, Whitaker N, Gonzalez-Rivera C. Mechanism and structure of the bacterial type IV secretion
systems. Biochimica et biophysica acta. 2014; 1843(8):1578–91. doi: 10.1016/j.bbamcr.2013.12.019
PMID: 24389247; PubMed Central PMCID: PMC4061277.
23. Kuramoto M, Yamada K, Shikano M, Yazawa K, Arimoto H, Okamura T, et al. Tanzawaic Acids A, B, C,
and D: Inhibitors of Superoxide Anion Production from Penicillium citrinum. Chemistry Letters.
1997:885–6.
24. Malmstrom J, Christophersen C, Frisvad JC. Secondary metabolites characteristic of Penicillium citri-
num, Penicillium steckii and related species. Phytochemistry. 2000; 54(3):301–9. PMID: 10870185.
25. Taylor DE, Gibreel A, Lawley TD, Tracz DM. Antibiotic resistance plasmids. In: Funnel BE, Phillips GJ,
editors. Plasmid Biology. Washington, DC: ASM Press; 2004. p. 473–91.
26. Quang TH, Ngan NT, KoW, Kim DC, Yoon CS, Sohn JH, et al. Tanzawaic acid derivatives from a
marine isolate of Penicillium sp. (SF-6013) with anti-inflammatory and PTP1B inhibitory activities.
Bioorganic & medicinal chemistry letters. 2014; 24(24):5787–91. Epub 2014/12/03. doi: 10.1016/j.
bmcl.2014.10.035 PMID: 25453820.
27. Sandjo LP, Thines E, Opatz T, Schuffler A. Tanzawaic acids I-L: Four new polyketides from Penicillium
sp. IBWF104-06. Beilstein J Org Chem. 2014; 10:251–8. Epub 2014/03/08. doi: 10.3762/bjoc.10.20
PMID: 24605144; PubMed Central PMCID: PMC3943810.
28. Cardoso-Martinez F, de la Rosa JM, Diaz-Marrero AR, Darias J, Cerella C, Diederich M, et al. Tanza-
waic acids isolated from a marine-derived fungus of the genus Penicillium with cytotoxic activities. Org
Biomol Chem. 2015; 13(26):7248–56. Epub 2015/06/10. doi: 10.1039/c5ob00773a PMID: 26055397.
29. Di Vaio C, Nocerino S, Paduano A, Sacchi R. Influence of some environmental factors on drupe matu-
ration and olive oil composition. J Sci Food Agric. 2013; 93(5):1134–9. Epub 2012/09/01. doi: 10.1002/
jsfa.5863 PMID: 22936522.
30. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrobial agents and chemother-
apy. 2009; 53(6):2227–38. Epub 2009/03/25. doi: 10.1128/AAC.01707-08 PMID: 19307361; PubMed
Central PMCID: PMC2687249.
31. Grant SG, Jessee J, Bloom FR, Hanahan D. Differential plasmid rescue from transgenic mouse DNAs
into Escherichia coli methylation-restriction mutants. Proceedings of the National Academy of Sciences
of the United States of America. 1990; 87(12):4645–9. PMID: 2162051.
32. Miller JH, Reznikoff WS, Silverstone AE, Ippen K, Signer ER, Beckwith JR. Fusions of the lac and trp
Regions of the Escherichia coli Chromosome. Journal of bacteriology. 1970; 104(3):1273–9. PMID:
16559103.
33. Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expres-
sion of cloned genes. Journal of molecular biology. 1986; 189(1):113–30. PMID: 3537305.
34. Posfai G, Plunkett G 3rd, Feher T, Frisch D, Keil GM, Umenhoffer K, et al. Emergent properties of
reduced-genome Escherichia coli. Science (New York, NY. 2006; 312(5776):1044–6. PMID:
16645050.
35. Taylor DE, Levine JG. Studies of temperature-sensitive transfer and maintenance of H incompatibility
group plasmids. Journal of general microbiology. 1980; 116(2):475–84. Epub 1980/02/01. PMID:
6989956.
Natural Conjugation Inhibitors
PLOS ONE | DOI:10.1371/journal.pone.0148098 January 26, 2016 12 / 13
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and
cytotoxicity assays. Journal of immunological methods. 1983; 65(1–2):55–63. Epub 1983/12/16. PMID:
6606682.
37. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazo-
lium dye procedure giving improved sensitivity and reliability. Journal of immunological methods. 1986;
89(2):271–7. Epub 1986/05/22. PMID: 3486233.
38. Amit M, Margulets V, Segev H, Shariki K, Laevsky I, Coleman R, et al. Human feeder layers for human
embryonic stem cells. Biol Reprod. 2003; 68(6):2150–6. Epub 2003/02/28. doi: 10.1095/biolreprod.
102.012583 PMID: 12606388.
39. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human
lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976; 17(1):62–70. Epub
1976/01/15. PMID: 175022.
40. Reske-Kunz AB, Rude E. Analysis of the (H-2b X H-2k)F1-restricted response to insulin. Ab alpha Ak
beta hybrid Ia molecules restrict the response towards the glutamic acid A4 epitope. Scand J Immunol.
1984; 20(2):97–104. Epub 1984/08/01. PMID: 6206556.
41. Verovski VN, Van den Berge DL, Delvaeye MM, Scheper RJ, De NeveWJ, Storme GA. Low-level
doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells impli-
cates a brefeldin A-sensitive mechanism of drug extrusion. Br J Cancer. 1996; 73(5):596–602. Epub
1996/03/01. PMID: 8605092; PubMed Central PMCID: PMC2074337.
42. Stein GH. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1
arrest in vitro. J Cell Physiol. 1979; 99(1):43–54. Epub 1979/04/01. doi: 10.1002/jcp.1040990107
PMID: 222778.
43. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory
concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163–75. Epub 2008/02/16. doi:
10.1038/nprot.2007.521 PMID: 18274517.
Natural Conjugation Inhibitors
PLOS ONE | DOI:10.1371/journal.pone.0148098 January 26, 2016 13 / 13
